AMD Integrative Biology Initiative

About Us

The AMD Integrative Biology Initiative aims to build on the AREDS2 clinical research study by:

  • correlating clinical AMD disease phenotypes with patient genotype and imaging information,

  • making the Initiative available to the research community with induced pluripotent stem cells (iPSCs) derived from participants with specific genetic risk factors in partnership with the New York Stem Cell Foundation Research Institute (NYSCF).